arch49
  • 30,00 EUR

    Making print for private purpose, storage in computer memory, no distribution rights.

  • 40,00 EUR

    Strictly for editorial, single use on a personal (nonprofit) web site, Internet portal, social media (Facebook, Instagram etc.), blog for 1 year. Not for resale. Maximum picture size 2000px.

  • 75,00 EUR

    Strictly for editorial, single use on a commercial web site, Internet portal, social media (Facebook, Instagram etc.), blog for 1 year. Not for resale. Maximum picture size 2000px.

  • 90,00 EUR

    Strictly for editorial, single use, inside of newspaper, magazine, book (including digital version), one edition, one single country. Not for resale.

Gross prices
Contact us to calculate price for another use. Prices only for online sales.
RESTRICTED TO EDITORIAL USE - MANDATORY CREDIT "AFP PHOTO /Merck & Co,Inc./HANDOUT" - NO MARKETING - NO ADVERTISING CAMPAIGNS - DISTRIBUTED AS A SERVICE TO CLIENTS
(FILES) This handout file photo obtained May 26, 2021, courtesy of Merck & Co, Inc. shows capsules of the investigational antiviral pill Molnupiravir. - The US Food and Drug Administration (FDA) on Thursday authorized Merck's Covid pill, Molnupiravir, for high risk adults, a day after a similar pill by Pfizer was given the green light. "Today's authorization provides an additional treatment option against the COVID-19 virus in the form of a pill that can be taken orally," said FDA scientist Patrizia Cavazzoni. (Photo by Handout / Merck & Co,Inc. / AFP) / RESTRICTED TO EDITORIAL USE - MANDATORY CREDIT "AFP PHOTO /Merck & Co,Inc./HANDOUT" - NO MARKETING - NO ADVERTISING CAMPAIGNS - DISTRIBUTED AS A SERVICE TO CLIENTS
More >><< Less
arch49
2021-05-26
HANDOUT/AFP/East News
AFP
HANDOUT
AFP_9V747F
1,1MB
27cm x 15cm by 300dpi
2021, 26, A, ADDITIONAL, ADMINISTRATION, ADULTS, ADVERTISING, AFTER, AGAINST, AN, AND, ANTIVIRAL, AS, AUTHORIZATION, AUTHORIZED, BE, BY, CAMPAIGNS, CAN, CAPSULES, CAVAZZONI, CLIENTS, CO, COURTESY, COVID, COVID-19, CREDIT, DAY, DISTRIBUTED, DRUG, EDITORIAL, FDA, FILE, FILES, FOOD, FOR, FORM, GIVEN, GREEN, HANDOUT, HEALTH, HIGH, HORIZONTAL, IN, INC, INVESTIGATIONAL, LIGHT, MANDATORY, MARKETING, MAY, MEDICINE, MERCK, MOLNUPIRAVIR, NO, OBTAINED, OF, ON, OPTION, ORALLY, PATRIZIA, PFIZER, PILL, PROVIDES, RESTRICTED, RISK, SAID, SCIENTIST, SERVICE, SHOWS, SIMILAR, TAKEN, THAT, THE, THIS, THURSDAY, TO, TODAY, TREATMENT, US, USE, VIRUS, WAS,